Desacetylcinobufagin has been shown to inhibit the growth of human tumor cells and induce apoptosis by inhibiting protein synthesis, which leads to cell death. Desacetylcinobufagin also inhibits the production of pro-inflammatory cytokines such as IL-1β and TNF-α by downregulating the expression of NF-κB, thereby reducing inflammation. Desacetylcinobufagin has been shown to be effective at preventing the development of tumors in both mice and rats. This compound has also been shown to have anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis. This product can be used for content determination, identification, and pharmacological experiments, etc.
Molecular Weight
400.51
Molecular Formula
C24H32O5
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Desacetylcinobufagin can be used for content determination, identification, and pharmacological experiments, etc.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
